Australia · Delayed Price · Currency is AUD Aroa Biosurgery Company Description
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; and Myriad Morcells, Myriad Morcells Fine, Myriad Meshed, and Symphony products for the treatment of partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds, trauma wounds, and draining wounds.
The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe.
Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.
| Country | New Zealand |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Brian Ward |
Contact Details
Address: 64 Richard Pearse Drive Auckland, 2022 New Zealand | |
| Phone | 64 9 869 3035 |
| Website | aroa.com |
Stock Details
| Ticker Symbol | ARX |
| Exchange | Australian Securities Exchange |
| Fiscal Year | April - March |
| Reporting Currency | NZD |
| ISIN Number | NZARXE0001S1 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Brian Ward B.V.Sc, MBA(dist) | Founder, Chief Executive Officer, MD and Executive Director |
| James Agnew BCom, LLB | Chief Financial Officer and Joint Company Secretary |
| Rod Stanley M.Sc. | Chief Operating Officer |
| Yasmin Winchester B.Sc. | Chief of Technical Operations |
| Dr. Barnaby C.H. May Ph.D. | Chief Scientific Officer |
| Michael Lynskey | Chief Commercial Officer |
| Tracy Weimar BA, MBA | Joint Company Secretary |
| Adam Young Ph.D. | Vice President of Medical Affairs |
| Sarah Tora | Media Executive |